VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HHS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HHSHarte Hanks, Inc.
$2.22$16M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHHSCash Flow

Harte Hanks, Inc. (HHS) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow generation remains elusive, with the most recent period recording a $903,000 outflow and erratic OCF/NI ratios that have swung as high as 32.31 in previous quarters.

HHS Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations-704K-1.74M-2.99M10.48M28.79M-1.76M-7.84M12.1M-9.18M-30.8M14.59M30.94M25.56M59.57M76.32M60.66M95.38M114.02M116.7M143.22M146.37M145.41M153.32M124.06M141.64M152.94M110.92M115.4M-170.2M92.7M72.5M
Operating CF Margin %--1.09%-1.61%5.47%13.96%-0.91%-4.43%5.56%-3.23%-8.02%3.61%6.25%4.62%10.65%9.94%7.13%11.08%13.26%10.78%12.32%12.36%12.81%14.88%13.13%15.59%16.66%11.55%13.91%-22.74%14.52%10.89%
Operating CF Growth %-161.96%41.91%-128.51%-63.61%1733.13%77.51%-164.81%231.76%70.19%-311.1%-52.85%21.06%-57.09%-21.95%25.81%-36.4%-16.35%-2.3%-18.51%-2.16%0.66%-5.15%23.58%-12.41%-7.39%37.88%-3.88%167.8%-283.6%27.86%98.63%
Net Income-1.05M-811K-30.3M-1.57M36.78M14.97M-1.69M-26.26M17.55M-41.86M-89.78M-170.93M23.99M24.44M-65.98M-215K53.6M47.72M62.74M92.64M111.79M114.46M97.57M87.36M90.75M79.68M81.89M72.9M68.4M336.7M40.6M
Depreciation & Amortization4.49M4.47M4.38M4.24M2.73M2.56M3.62M5.34M7.45M10.5M12.35M14.24M14.92M15.74M20.42M21.21M23.43M29.98M36.38M36.7M34.03M31.51M28.87M30.13M32.83M49.13M44.16M35.2M29.6M23.2M31.1M
Stock-Based Compensation157K258K1.93M1.42M2.35M1.47M764K1.07M-581K2.66M2.67M5.73M4.05M5.74M3.41M4.99M3.91M3.89M5.83M7.07M7.43M161K101K100K0000000
Deferred Taxes-917K-928K-9.28M-1.47M-19.84M-10.72M-244K996K-1.65M-10.96M26.29M-41.23M5.8M1.74M-43.52M11.93M8.92M6.09M13.53M8.63M6.72M6.55M6.96M12.05M8.88M2.47M5.94M10.6M4.1M2.7M600K
Other Non-Cash Items-2M-3.1M33.9M380K-1.01M913K-3.94M7.58M-25.63M39.74M13.09M221.84M-2.86M16.35M161.55M41.66M6.57M9.06M-150K5.17M6.06M459K534K379K741K4.46M-4.09M-3M-266.1M-533.1M600K
Working Capital Changes-1.38M-1.63M-3.63M7.49M7.79M-10.96M-6.34M23.37M-6.33M-30.89M49.96M1.29M-20.34M-4.44M432K-19.12M-1.05M17.29M-1.63M72K-12.23M-7.56M19.38M-5.86M8.45M17.2M-16.98M-300K-6.2M263.2M-400K
Change in Receivables6.06M4.97M2.38M5.65M3.84M-9.18M-931K16.82M7.47M7.42M14.95M10.19M-5.17M7.63M12.99M-5.39M-8.74M29.36M31.48M-10.25M-460K-14.25M-14.21M-15.02M0000000
Change in Inventory000000308K94K139K251K125K272K51K-507K613K214K-2.48M2.63M-1.47M1.95M23K-1.08M-873K86K536K425K839K-800K900K2.4M11.9M
Change in Payables-4.82M-3.21M-795K844K6.2M-395K-997K-13.75M9.25M-10.4M9.13M2.14M-278K-1.34M-3.4M-9.71M12.66M-5.8M-21.55M8.31M1.92M6.17M7.44M7.14M0000000
Cash from Investing-3M-2.76M-3.74M-2.31M-11.49M-2.9M-775K-2.6M-52K-5.67M99.7M-36.16M-11.1M10.35M-13.84M-17.55M-30.15M-8.87M-28.3M-28.1M-86.76M-91.32M-64.58M-31.64M-20.71M-53.38M-79.52M-29.6M185.2M231.7M-61.1M
Capital Expenditures-3M-2.76M-3.75M-2.81M-5.8M-3.05M-2.7M-2.9M-4.21M-5.68M-6.69M-11.57M-11.27M-15.87M-13.86M-21.03M-17.45M-9.01M-19.95M-28.22M-33.71M-28.21M-35.15M-31.91M-17.36M-26.45M-36.47M-165.4M-71.8M-147.5M-27.4M
CapEx % of Revenue1.93%1.73%2.02%1.47%2.81%1.57%1.53%1.33%1.48%1.48%1.65%2.34%2.03%2.84%1.8%2.47%2.03%1.05%1.84%2.43%2.85%2.49%3.41%3.38%1.91%2.88%3.8%19.93%9.59%23.11%4.11%
Acquisitions-1K1K0500K-5.75M146K1.92M300K3.93M18K-3.5M-24.89M0000-12.9M-8.69M-8.69M0-53.93M-63.27M-29.7M-343K-3.79M-28.23M-43.87M0000
Investments-------------------------------
Other Investing002K3K57K000225K18K109.89M297K169K26.22M12K3.48M207K142K339K120K877K165K268K621K439K1.29M823K-3.1M7.2M765.9M-33.7M
Cash from Financing632K514K-419K-3.22M-15.82M-13.41M7.31M3.09M22.73M-1.46M-85.3M-31.94M-44.63M-30.02M-99.83M-42.18M-65.75M-49.48M-79.7M-130.84M-46.22M-68.34M-82.08M-85.3M-126.37M-92.02M-43.68M-81M-68.3M-252.8M-17.5M
Debt Issued (Net)-160K-159K-124K-160K-5.19M-12.33M7.99M3.69M13.65M-712K-77.48M-5.38M-15.31M-12.25M-69.19M-14.37M-46.69M-30.94M11.5M54.13M143M52M5M-11.3M-32.53M-10M53.49M5M0-216.9M-22.6M
Equity Issued (Net)-46K-65K-295K-3.01M-10.49M-291K-22K9K0-111K-47K-5.33M-7.35M-1.11M-3.74M-7.65M75K555K-72.45M-167.12M-173.27M-103.63M-73.29M-63.38M-84.69M-74.46M-90.44M-80.4M-63.9M-33M7.5M
Dividends Paid0000000000-5.29M-21.24M-21.48M-16.12M-26.96M-20.37M-19.14M-19.12M-19.1M-20.3M-18.9M-16.7M-13.79M-10.62M-9.15M-7.56M-6.74M-5.6M-4.4M-3M-2.4M
Share Repurchases-46K-65K-295K-3.01M-469K-291K-22K-6K-115K00-4.62M-7.83M-1.63M-4.4M-8.36M00-76.65M-183.87M-186M-114.21M-85.74M-76.39M-98.91M-83.66M-97.02M-87.6M-71.4M-47.3M0
Other Financing838K738K0-45K-131K-795K-653K-616K9.08M-635K-2.48M14K-481K-539K57K215K013K342K2.46M2.95M00000000100K0
Net Change in Cash-4.44M-4.35M-8.93M7.5M-3.77M-18.43M-560K13.24M12.48M-37.61M29.44M-39.14M-32M39.36M-37.13M782K-602K56.44M7.31M-15.42M13.71M-14.25M6.66M7.13M-5.44M7.54M-12.27M4.8M-53.3M71.6M-6.1M
Free Cash Flow-3.7M-4.49M-6.73M7.67M22.99M-4.81M-10.54M9.2M-13.39M-36.48M7.9M19.37M14.3M43.7M62.47M39.63M77.93M105.01M96.75M115M112.66M117.2M118.17M92.15M124.28M126.5M74.46M-50M-242M-54.8M45.1M
FCF Margin %-2.38%-2.82%-3.63%4%11.15%-2.47%-5.96%4.23%-4.7%-9.5%1.95%3.91%2.58%7.81%8.14%4.66%9.06%12.21%8.94%9.89%9.51%10.33%11.47%9.76%13.68%13.78%7.75%-6.03%-32.33%-8.59%6.77%
FCF Growth %-234.21%33.28%-187.84%-66.66%578.1%54.37%-214.53%168.74%63.31%-561.88%-59.22%35.49%-67.29%-30.04%57.62%-49.14%-25.79%8.53%-15.86%2.07%-3.87%-0.82%28.24%-25.85%-1.75%69.88%248.92%79.34%-341.61%-221.51%136.13%
FCF per Share-0.50-0.61-0.921.053.11-0.67-1.631.46-2.14-5.891.283.142.286.969.936.2412.1516.4415.0915.6013.9713.7213.4610.2413.1013.027.13-4.62-21.21-4.753.93
FCF Conversion (FCF/Net Income)3.54x2.14x0.10x-6.67x0.78x-0.12x4.63x-0.46x-0.52x0.74x-0.11x-0.18x1.07x4.46x-0.92x1.37x1.78x2.39x1.86x1.55x1.31x1.27x1.57x1.42x1.56x1.92x1.35x1.58x-2.49x0.28x1.79x
Interest Paid00000490K000292K5.67M1.68M0000000000000000000
Taxes Paid001.45M001.32M00032.91M2.59M10.07M0000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Persistent Revenue Attrition

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Remains Highly Volatile

As reported in recent financial filings, the relationship between net income and operating cash flow for HHS is erratic, with OCF/NI ratios swinging wildly from 0.89 to over 32.0, indicating that reported earnings provide little reliable insight into the company's actual ability to generate cash.

The extreme variance in the OCF/NI ratio suggests that accrual-based accounting adjustments are significantly distorting the company's bottom-line performance. Investors should monitor this divergence, as it implies that net income is frequently decoupled from the underlying cash-generating capacity of the business.

Free Cash Flow Trajectory Deteriorating

Based on the company's quarterly cash flow statements, free cash flow has remained largely negative, with the most recent period showing a $903,000 outflow, highlighting a persistent inability to sustain positive cash generation despite the company's efforts to manage its operational cost structure.

The consistent failure to produce positive free cash flow suggests that the business model is currently consuming capital rather than creating it. This trend warrants further investigation into whether the company can reach a sustainable inflection point without further eroding its cash reserves.

Working Capital Swings Mask Instability

According to historical data, working capital changes have been the primary driver of cash flow volatility, with swings as large as $6.1 million in a single quarter, suggesting that the company's cash position is highly sensitive to the timing of client payments and inventory management.

The reliance on working capital fluctuations to bridge cash flow gaps indicates a lack of operational predictability. This volatility appears to be a structural feature of the business, potentially reflecting the lumpy nature of project-based marketing contracts and fulfillment cycles.

Capital Intensity Remains Relatively Low

As evidenced by the reported figures, capital expenditures have remained modest, with CapEx/Revenue ratios consistently below 4%, suggesting that the company is not currently engaged in heavy asset investment to drive future growth or replace aging fulfillment infrastructure.

The low capital intensity may indicate that the company is prioritizing cash preservation over infrastructure modernization. While this protects the balance sheet in the short term, it may also limit the company's ability to compete effectively against larger, more technologically advanced peers.

HHS — Frequently Asked Questions

Quick answers to the most common questions about buying HHS stock.

How much cash does Harte Hanks, Inc. (HHS) generate from operations?

Harte Hanks, Inc. (HHS) generated $-1.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Harte Hanks, Inc.'s free cash flow?

Harte Hanks, Inc. (HHS) reported negative free cash flow of $4.5M in 2025, indicating capital requirements exceeded cash from operations.

What is Harte Hanks, Inc.'s capital expenditure (CapEx)?

Harte Hanks, Inc. (HHS) spent $2.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Harte Hanks, Inc. distribute cash to shareholders?

In 2025, Harte Hanks, Inc. (HHS) spent $0.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.